IMS: Stable revenue and narrowed loss, but future operations depend on securing new capital
· Issued by Invent Medic Sweden Ab
Revenue remained stable at 7,404 KSEK in 2025, with net loss reduced to -5,201 KSEK. Capital was raised to support growth, but the auditor highlighted a material uncertainty about continued operations due to future capital needs.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
